CD8A and neoplasm: Similarly, a ChAdOx1–MVA vaccination strategy (a simian adenovirus, ChAdOx1, with the modified vaccinia Ankara virus, MVA) induced CD8+ T-cell responses to the tumor-specific self-antigen of prostate 1 (STEAP1) in murine models.